| Literature DB >> 28292235 |
Leyong Zeng1,2, Di Wu1, Ruifen Zou2, Tianxiang Chen2, Jinchao Zhang1, Aiguo Wu2.
Abstract
Magnetic resonance imaging (MRI) has become a promising technique in the early diagnosis of cancers, especially the application of contrast agents can further enhance the detection limit. Compared with the dark signal in "negative" contrast agents (T2), "positive" contrast agents (T1) with bright signal are more desirable for high-resolution imaging. However, the clinically used gadolinium complexes have short circulation time and the risk of nephrogenic system fibrosis. Therefore, to overcome the disadvantage of T2 agents and traditional T1 agents, it is very interesting to develop nano-scaled T1-weighted MRI contrast agents with safer and more precise imaging performance. The present review systematically summarized the recent progress of paramagnetic and superparamagnetic inorganic nanoparticles as T1-weighted MRI contrast agents, including gadolinium oxide nanoparticles, gadoliniumbased upconversion nanoparticles, manganese oxide nanoparticles, and ultra-small iron oxide nanoparticles. Moreover, we also described their applications in multi-modal imaging and visualized theranostics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Paramagnetic and superparamagnetic inorganic nanoparticles; T1-weighted magnetic resonance imaging; gadolinium-based nanoparticles; manganesezzm321990oxides; ultra-small iron oxides; visualized theranostics.
Mesh:
Substances:
Year: 2018 PMID: 28292235 DOI: 10.2174/0929867324666170314124616
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530